Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Deep-learning based quantification of RPE65-mutation inherited retinal degeneration from wide-angle images – novel biomarkers for natural history and interventional studies.
Author Affiliations & Notes
  • Birgit Lorenz
    Ophthalmology, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
    Ophthalmology, Justus-Liebig-Universitat Giessen, Giessen, Hessen, Germany
  • Eduardo Dávila-Meza
    Departamento de Control, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Ciudad de Mexico, Ciudad de México, Mexico
  • Sandrine H. Künzel
    Ophthalmology, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Frank G Holz
    Ophthalmology, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Eduardo Bayro-Corrochano
    Departamento de Control, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Ciudad de Mexico, Ciudad de México, Mexico
  • Alexander Effland
    Institute of Applied Mathematics, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Footnotes
    Commercial Relationships   Birgit Lorenz Novartis; Janssen, Code C (Consultant/Contractor), Novartis, Code F (Financial Support); Eduardo Dávila-Meza None; Sandrine H. Künzel Novartis, Code C (Consultant/Contractor), Carl Zeiss MediTec, Jena, Germany; CenterVue, Padua, Italy; Heidelberg Engineering, Heidelberg, Germany; Optos, Dunfermline, UK, Code F (Financial Support), Chiesi, Hamburg, Germany, Code R (Recipient); Frank Holz Acucela, Alexion, Alzheon, Apellis, Astellas, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, Roche/Genentech, Geuder, Graybug, Gyroscope, Heidelberg Engineering, IvericBio, Janssen, Kanghong, LinBioscience, Novartis, Oxurion, Pixium Vision, Oxurion, Stealth BioTherapeutics, Zeiss, Code C (Consultant/Contractor), Acucela, Allergan, Apellis, Bayer, Formycon, CenterVue, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, NightStarX, Novartis, Optos, Pixium Vision, Zeiss;Code, Code F (Financial Support), Grade Reading Center, Code O (Owner); Eduardo Bayro-Corrochano None; Alexander Effland relios.vision GmbH, Code O (Owner)
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1392. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Birgit Lorenz, Eduardo Dávila-Meza, Sandrine H. Künzel, Frank G Holz, Eduardo Bayro-Corrochano, Alexander Effland; Deep-learning based quantification of RPE65-mutation inherited retinal degeneration from wide-angle images – novel biomarkers for natural history and interventional studies.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1392.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Subretinal gene therapy with Voretigene Neparvovec (VN) for inherited retinal degenerations with biallelic mutations in RPE65 (RPE65-IRD) maybe associated with accelerated retinal degeneration. Quantification of panretinal pathologies is an unmet need. We propose a deep-learning based algorithm to quantify progressive retinal changes in treatment naïve and treated patients using wide-angle color fundus photgraphs.

Methods : We trained a Mask R-CNN for automatized multi-class segmentation of distinct regions of interest (Fig. 1) representing different degrees of degeneration. We exploited a residual network for the underlying feature extraction with manual ground truth annotations for manual annotation on 150 Clarus 133° fundus images (17 patients, 34 eyes) and evaluated the performance of the algorithm on 32 Clarus 133° fundus images (6 patients, 12 eyes). Due to the relatively small size of the training dataset, we employed several data augmentation techniques including rotation, flipping, and adaption of contrast, intensity as well as color.

Results : Fig 2 shows pairs of ground truth annotations and segmentation predictions for bone spicules, spotty hyperpigmentations (top row), and marble-like pathology (bottom row). The proposed algoritihm exhibits a precision of 65.62% and a mean average precision 50 value of 67.3%, where insufficient segmentation masks are primarily due to the relatively small bone spicules and spotty hyperpigmentations.

Conclusions : The algorithm allows monitoring panretinal disease expression and progression based on the number and size of the predefined regions of interest and their spatial relation. Despite the use of a relatively small data set precision was acceptable. Transformer-type networks or the inclusion of synthesized training data using generative models can improve precision of the algorithm as well as including image sets from more patients. A larger cohort of RPE65-IRD patients was identified in the 2021 survey by the European Vision Institute for Research Net (EVICR.net) on the management of RPE65-IRDs in Europe.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Fig 1. Definition of six distinct fundus features in RPE65-IRDs (Clarus 133°, Zeiss Oberkochen, Germany)

Fig 1. Definition of six distinct fundus features in RPE65-IRDs (Clarus 133°, Zeiss Oberkochen, Germany)

 

Fig 2. Annotation of fundus features BS, SH and ML, and deep-learning segmentation with the novel algorithm.

Fig 2. Annotation of fundus features BS, SH and ML, and deep-learning segmentation with the novel algorithm.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×